Science

Chris Collins’ Indictment Reveals Dark Side of Immunotherapy

INSIDER TRADING

MIS416 was touted as a miracle drug that could potentially cure a severe form of multiple sclerosis. But it might have been hyped up too quickly.

Tanya Basu
Tanya Basu 

Senior Editor, Science

chris collins rep new york ny immunotherapy mis416 secondary progressive multiple sclerosis spms innate australia insider trading fraud
Tom Williams/Getty
Tanya Basu

Tanya Basu

Senior Editor, Science

tanyabasu

Got a tip? Send it to The Daily Beast here.

Trending Now
PoliticsHegseth’s Venmo Is on Display in Embarrassing Leak
Liam Archacki
PoliticsTrump Calls for ‘60 Minutes’ and CBS to Be ‘Terminated’
Sean Craig
PoliticsDOGE Staffer Jumps Ship After Pro-Eugenics Posts Surface
Emell Derra Adolphus
exclusiveHouse Republicans Implode: ‘Angry’ ‘Rude’ and ‘Frustrated’
Juliegrace Brufke
PoliticsEducation Staffers Warned: Trump Buyout Deal Comes With a Major Catch
Sean Craig